Evaluation of T1rho Magnetic Resonance Imaging for Diagnosis of Cartilage Lesions in Hips With Developmental Dysplasia

UnknownOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

July 25, 2017

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Developmental Dysplasia of the Hip
Interventions
RADIATION

Magnetic Resonance Imaging (MRI)

Patients will undergo 2 different MRIs of the affected hip. Both MRIs assess hip cartilage degeneration. A contrast agent, Gadolinium, will be used to visualize cartilage during the MRI. The contrast agent is injected through an intravenous (a small plastic tube inserted into a vein in the patients' arm) before the MRI.

Trial Locations (1)

K1H8L6

RECRUITING

Ottawa Hospital - General Campus, Ottawa

Sponsors
All Listed Sponsors
collaborator

Zimmer Biomet

INDUSTRY

collaborator

The Ottawa Hospital Academic Medical Association

OTHER

lead

Ottawa Hospital Research Institute

OTHER